Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
MAP Pharmaceuticals, Inc. (MAPP) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/07/2014 SC 13G/A JENNISON ASSOCIATES LLC reports a 0% stake in Map Pharmaceuticals, Inc.
02/07/2014 SC 13G/A PRUDENTIAL FINANCIAL INC has filed a Schedule 13D for MAP Pharmaceuticals, Inc.
03/13/2013 EFFECT Form EFFECT - Notice of Effectiveness
03/13/2013 EFFECT Form EFFECT - Notice of Effectiveness
03/13/2013 EFFECT Form EFFECT - Notice of Effectiveness
03/11/2013 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
03/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/11/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
03/11/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
03/11/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
03/04/2013 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 0% stake in MAP Pharmaceuticals, Inc.
03/01/2013 8-K Quarterly results
03/01/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/01/2013 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
03/01/2013 SC 13D/A MAP Pharmaceuticals, Inc. reports a 85.5% stake in MAP Pharmaceuticals, Inc.
02/11/2013 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/11/2013 SC 13G/A MAP Pharmaceuticals, Inc. reports a 6.9% stake in Map Pharmaceuticals, Inc.
02/11/2013 SC 13G/A MAP Pharmaceuticals, Inc. reports a 12.7% stake in MAP Pharmaceuticals, Inc.
01/24/2013 5 GIANAKAKOS ANASTASIOS (SVP, Chief Business Officer) has filed a Form 5 on MAP Pharmaceuticals, Inc.
01/24/2013 5 NELSON TIMOTHY S (President and CEO) has filed a Form 5 on MAP Pharmaceuticals, Inc.
01/24/2013 5 CHAI CHRISTOPHER Y (SVP & CFO) has filed a Form 5 on MAP Pharmaceuticals, Inc.
01/24/2013 5 KELLERMAN DONALD J (SVP,Clinical Dev & Med Affairs) has filed a Form 5 on MAP Pharmaceuticals, Inc.
01/24/2013 5 Borland Scott (SVP, Neurology Franchise) has filed a Form 5 on MAP Pharmaceuticals, Inc.
01/23/2013 8-K Form 8-K - Current report
01/23/2013 SC14D9C Form SC14D9C - Written communication relating to third party tender offer
11/21/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA Resubmission for LEVADEX® --New PDUFA date April 15, 2013--"
11/06/2012 10-Q Quarterly Report for the period ended September 30, 2012
11/01/2012 8-K Quarterly results
Docs: "MAP Pharmaceuticals Reports Third Quarter of 2012 Financial Results"
10/16/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "MAP Pharmaceuticals Resubmits New Drug Application to FDA for LEVADEX® Orally Inhaled Migraine Drug"
08/29/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "FOR IMMEDIATE DISTRIBUTION"
08/29/2012 PRN MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock
08/01/2012 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Form of underwriting agreement",
"Opinion of Latham & Watkins LLP",
"FOR IMMEDIATE DISTRIBUTION"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy